(Q40790004)

23 September 2017

1 reference

title

Adverse effects of intravenous immunoglobulin (English)

1 reference

23 September 2017

S A Misbah

1

1 reference

PubMed ID

8260119

23 September 2017

H M Chapel

series ordinal

2

1 reference

23 September 2017

1 October 1993

1 reference

23 September 2017

1 reference

23 September 2017

9

1 reference

23 September 2017

254-262

1 reference

23 September 2017

4

1 reference

https://scigraph.springernature.com/pub.10.2165/00002018-199309040-00003

23 September 2017

0 references

cites work

Hyperviscosity in HIV infected children--a potential hazard during intravenous immunoglobulin therapy

1 reference

12 December 2020

Renal failure and intravenous immunoglobulin

1 reference

12 December 2020

Administration of immune globulin associated with aseptic meningitis

1 reference

12 December 2020

Anti-idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous gammaglobulin

1 reference

12 December 2020

Elimination of infectious retroviruses during preparation of immunoglobulins

1 reference

12 December 2020

Intravenous immune globulin and acute aseptic meningitis

1 reference

12 December 2020

Erythema multiforme after intravenous immunoglobulin

1 reference

12 December 2020

Intravenous immunoglobulin for the prevention of infection in chronic lymphocytic leukemia. A randomized, controlled clinical trial

1 reference

12 December 2020

Anti-idiotypes against anti-neutrophil cytoplasmic antigen autoantibodies in normal human polyspecific IgG for therapeutic use and in the remission sera of patients with systemic vasculitis

1 reference

12 December 2020

Intravenous immune globulin: a cautionary note

1 reference

12 December 2020

Acute cryoglobulinemic renal failure after intravenous infusion of gamma globulin

1 reference

12 December 2020

A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group

1 reference

12 December 2020

Benefit of intravenous IgG replacement in hypogammaglobulinemic patients with chronic sinopulmonary disease

1 reference

12 December 2020

High-dose intravenous immune globulin and acute renal failure

1 reference

12 December 2020

Intravenous immune globulin for the prevention of bacterial infections in children with symptomatic human immunodeficiency virus infection

1 reference

12 December 2020

Cerebral infarction complicating intravenous immunoglobulin therapy for polyneuritis cranialis

1 reference

12 December 2020

Renal toxicity of intravenous immunoglobulin

1 reference

12 December 2020

Seroconversion for hepatitis C virus antibody in bone marrow recipients treated with immune globulin

1 reference

12 December 2020

Predictors of infection in chronic lymphocytic leukaemia (CLL)

1 reference

12 December 2020

Transient Neutropenia Induced by Intravenous Immune Globulin

1 reference

12 December 2020

The Treatment of Kawasaki Syndrome with Intravenous Gamma Globulin

1 reference

12 December 2020

Use of intravenous gamma-globulin in antibody immunodeficiency: results of a multicenter controlled trial

1 reference

12 December 2020

Eczema after intravenous infusion of immunoglobulin

1 reference

12 December 2020

Treatment of systemic vasculitis with pooled intravenous immunoglobulin

1 reference

12 December 2020

Appropriate uses of human immunoglobulin in clinical practice: memorandum from an IUIS/WHO meeting

1 reference

12 December 2020

Recurrent aseptic meningitis complicating intravenous immunoglobulin therapy for chronic inflammatory demyelinating polyradiculoneuropathy

1 reference

12 December 2020

Anaphylaxis after administration of gamma globulin for hypogammaglobulinemia

1 reference

12 December 2020

Mechanism of therapeutic effect of high-dose intravenous immunoglobulin. Attenuation of acute, complement-dependent immune damage in a guinea pig model

1 reference

12 December 2020

Intravenous immunoglobulin prophylaxis causing liver damage in 16 of 77 patients with hypogammaglobulinemia or IgG subclass deficiency

1 reference

12 December 2020

Intravenous Immune Globulin and Aseptic Meningitis

1 reference

12 December 2020

Uveitis and antineutrophil cytoplasmic antibody in immunoglobulin batches

1 reference

12 December 2020

Hypogammaglobulinaemia in the United Kingdom. Summary report of a Medical Research Council working-party

1 reference

12 December 2020

Transmission of non-A, non-B hepatitis by pH4-treated intravenous immunoglobulin

1 reference

12 December 2020

Effect of high-dose intravenous immunoglobulin therapy on blood rheology

1 reference

12 December 2020

Alopecia after immunoglobulin infusion

1 reference

12 December 2020

Anaphylactic reactions after gamma globulin administration in patients with hypogammaglobulinemia. Detection of IgE antibodies to IgA

1 reference

12 December 2020

A Single Intravenous Infusion of Gamma Globulin as Compared with Four Infusions in the Treatment of Acute Kawasaki Syndrome

1 reference

12 December 2020

Crossover study of immunoglobulin replacement therapy in patients with low-grade B-cell tumors.

1 reference

12 December 2020

Immune hemolysis, disseminated intravascular coagulation, and serum sickness after large doses of immune globulin given intravenously for Kawasaki disease

1 reference

12 December 2020

Fatal thrombotic events during treatment of autoimmune thrombocytopenia with intravenous immunoglobulin in elderly patients

1 reference

12 December 2020

Spurious serologic test results in patients receiving infusions of intravenous immune gammaglobulin

1 reference

12 December 2020

Hemolytic anemia following intravenous gamma globulin administration

1 reference

12 December 2020

Intravenous immunoglobulin therapy in patients with multiple myeloma.

1 reference

12 December 2020

High-dose intravenous IgG treatment and renal function

1 reference

12 December 2020

Intravenous administration of human gamma-globulin

1 reference

12 December 2020

Pulmonary and renal toxicity of intravenous immunoglobulin

1 reference

12 December 2020

Haemolysis induced by intravenously-administered immunoglobulin.

1 reference

12 December 2020

Screening for hepatitis C virus antibody in plasma for fractionation

1 reference

12 December 2020

Non-A, non-B hepatitis occurring in agammaglobulinaemic patients after intravenous immunoglobulin

1 reference

12 December 2020

Improvement of histological and immunological change in steroid and immunosuppressive drug-resistant lupus nephritis by high-dose intravenous gamma globulin.

1 reference

12 December 2020

Acute renal failure resulting from intravenous immunoglobulin therapy

1 reference

12 December 2020

Intravenous IgG for glomerulonephritis and renal function

1 reference

12 December 2020

Anti-HCV screening and plasma fractionation: the case against

1 reference

12 December 2020

Immunoglobulin prophylaxis in patients with antibody deficiency syndromes and anti-IgA antibodies

1 reference

12 December 2020

Modulation of Fc receptor clearance and antiplatelet antibodies as a consequence of intravenous immune globulin infusion in patients with immune thrombocytopenic purpura

1 reference

12 December 2020

Uveitis after antineutrophil cytoplasmic antibody contamination of immunoglobulin replacement therapy

1 reference

12 December 2020

Use of high-dose intravenous immunoglobulin in systemic lupus erythematosus: report of three cases

1 reference

12 December 2020

CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. I. THE CHARACTERIZATION OF THE PROTEIN FRACTIONS OF HUMAN PLASMA.

1 reference

12 December 2020

10.2165/00002018-199309040-00003

Identifiers

DOI

1 reference

PubMed ID

8260119

Dimensions Publication ID

23 September 2017

0 references

1 reference

PubMed ID

8260119